Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Clinical trial NCT05910528 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05910528
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-24
- Primary completion
- 2026-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.